Literature DB >> 17708604

Syndrome differentiation in traditional Chinese medicine and E-cadherin/ICAM-1 gene protein expression in gastric carcinoma.

Da-Zhi Sun1, Ling Xu, Pin-Kang Wei, Long Liu, Jin He.   

Abstract

AIM: To explore the syndrome differentiation in traditional Chinese medicine (TCM) and gene protein expression in gastric carcinoma.
METHODS: Preoperative data of gastric cancer cases were collected from the General Surgery Department and classified according to the criteria for syndrome differentiation in TCM. E-cadherin (E-cad) and ICAM-1 gene protein expressions were detected in postoperative specimens from these cases by the immunohistochemical EnVision two-step method.
RESULTS: The E-cad positive expression rate was 90% in 100 cases of gastric carcinoma. The difference in E-cad expression was significant between the different syndrome differentiation types in TCM (P < 0.01). Further group-group comparison showed that there was a significant difference in E-cad expression between the stagnation of phlegm-damp type and the deficiency in both qi and blood and the deficiency-cold of stomach and spleen types, where E-cad expression was high. There was no significant difference between the internal obstruction of stagnant toxin type and the in-coordination between liver and stomach type, where E-cad expression was relatively low. The ICAM-1 positive expression rate was 58%, and there was no statistically significant difference between the two groups (c2 = 8.999, P > 0.05).
CONCLUSION: E-cad expression is relatively low in the internal obstruction of stagnant toxin type and the in-coordination between liver and stomach type, where tumor development and metastasis may be associated with low E-cad expression, or with low homogeneous adhesiveness between tumor cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17708604      PMCID: PMC4250857          DOI: 10.3748/wjg.v13.i32.4321

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

Review 1.  The use of molecular biology in diagnosis and prognosis of gastric cancer.

Authors:  K F Becker; G Keller; H Hoefler
Journal:  Surg Oncol       Date:  2000-07       Impact factor: 3.279

2.  Lipid-mediated gene transfection of intercellular adhesion molecule-1 suppresses the peritoneal metastasis of gastric carcinoma.

Authors:  Hiroaki Tanaka; Masakazu Yashiro; Takeshi Sunami; Masaichi Ohira; K Hirakawa-Y S Chung
Journal:  Int J Mol Med       Date:  2002-11       Impact factor: 4.101

3.  Rapid detection of mutated E-cadherin in peritoneal lavage specimens from patients with diffuse-type gastric carcinoma.

Authors:  C Schuhmacher; K F Becker; U Reich; U Schenk; J Mueller; J R Siewert; H Höfler
Journal:  Diagn Mol Pathol       Date:  1999-06

4.  [Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer].

Authors:  Pablo Guzmán; Juan Araya; Miguel Villaseca; Iván Roa; Angélica Melo; Sergio Muñoz; Juan Roa
Journal:  Rev Med Chil       Date:  2006-11-14       Impact factor: 0.553

5.  Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer.

Authors:  J H Lee; J T Koh; B A Shin; K Y Ahn; J H Roh; Y J Kim; K K Kim
Journal:  Int J Oncol       Date:  2001-02       Impact factor: 5.650

6.  alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives.

Authors:  J Yu; M P Ebert; S Miehlke; H Rost; U Lendeckel; A Leodolter; M Stolte; E Bayerdörffer; P Malfertheiner
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

7.  E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.

Authors:  B Mayer; J P Johnson; F Leitl; K W Jauch; M M Heiss; F W Schildberg; W Birchmeier; I Funke
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

8.  A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development.

Authors:  D Riethmacher; V Brinkmann; C Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 9.  Mutations of the human E-cadherin (CDH1) gene.

Authors:  G Berx; K F Becker; H Höfler; F van Roy
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

10.  [Relationship between E-cadherin and growth pattern of gastric cancer and degree of cell differentiation].

Authors:  J C Cai; S J Jiang; Z P Chen
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  1994
View more
  5 in total

1.  Therapeutic effect of Jinlongshe Granule () on quality of life of stage IV gastric cancer patients using EORTC QLQ-C30: A double-blind placebo-controlled clinical trial.

Authors:  Da-zhi Sun; Jian-peng Jiao; Xuan Zhang; Jing-yu Xu; Min Ye; Li-juan Xiu; Ying Zhao; Ye Lu; Xuan Liu; Jing Zhao; Jun Shi; Zhi-feng Qin; Pin-kang Wei
Journal:  Chin J Integr Med       Date:  2014-11-16       Impact factor: 1.978

2.  Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of "tumor-phlegm microenvironment".

Authors:  Da-zhi Sun; Jian-peng Jiao; Da-wei Ju; Min Ye; Xuan Zhang; Jing-yu Xu; Ye Lu; Jin He; Pin-kang Wei; Ming-hui Yang
Journal:  Chin J Integr Med       Date:  2012-05-02       Impact factor: 1.978

Review 3.  Recent Advances and Perspective of Studies on Phlegm Syndrome in Chinese Medicine.

Authors:  Zhiguo Zhang; Jingqing Hu
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-14       Impact factor: 2.629

4.  A Study of Logistic Regression for Fatigue Classification Based on Data of Tongue and Pulse.

Authors:  Yu Lin Shi; Tao Jiang; Xiao Juan Hu; Ji Cui; Long Tao Cui; Li Ping Tu; Xing Hua Yao; Jing Bin Huang; Jia Tuo Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-05       Impact factor: 2.629

5.  A systems biology approach to understanding the mechanisms of action of chinese herbs for treatment of cardiovascular disease.

Authors:  Bohui Li; Xue Xu; Xia Wang; Hua Yu; Xiuxiu Li; Weiyang Tao; Yonghua Wang; Ling Yang
Journal:  Int J Mol Sci       Date:  2012-10-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.